Who we are:
Calico is a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan, and to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.
Calico is seeking a clinical biostatistician with extensive experience in First-in-Human (FIH) studies in bringing novel therapeutics to the clinic. The successful candidate will join a small clinical team responsible for advancing exciting drug candidates into clinical trials to treat diseases with high unmet medical need. The objective is to create an agile team to navigate new terrain in the approach to the early stages of drug development and would involve participation in cross-functional team meetings providing statistical support to early stage development programs.
Calico’s approach to drug development is supported by some of the world’s most talented life scientists. This position offers a unique opportunity to build an effective and efficient approach to drug development at the leading edge of evolution in scientific knowledge, and the opportunity to collaborate with our innovative Computational group, including computational biologists, data scientists, machine learning and data platform engineers.